• Rho Showcases Clinical Services Expertise at OCT East Coast

    May 21, 2015, 00:00 AM by Michael Croft
    CHAPEL HILL, NC - May 21, 2015 -   Rho Showcases Clinical Services Expertise at OCT East Coast WHAT:           Rho, a full-service contract research organization (CRO), will highlight its continued success in drug development strategies and services during the 6th annual Outsourcing in Clinical Trials (OCT) East Coast conference, being held May 27-28 in King of Prussia, Pennsylvania
    Full story
  • KCR Accomplishes ISO 9001:2008 Certification for All Company Services

    May 21, 2015, 00:00 AM by Michael Croft
    BERLIN, GERMANY - May 21, 2015 - KCR, a Contract Research Organization (CRO), operating in 19 countries in Europe as well as the U.S., has recently validated the quality and accuracy of its operations receiving ISO 9001:2008 Certification for all its services
    Full story
  • Biodesix Launches GeneStrat Targeted Liquid Biopsy Mutation Test For Patients With Advanced Lung Cancer

    May 21, 2015, 00:00 AM by Michael Croft
    BOULDER, CO, UNITED STATES - May 21, 2015 - BOULDER, Colo.—May 21, 2015—Biodesix, Inc. today announced the launch of GeneStrat™, a targeted liquid biopsy mutation test for genotyping tumors of patients with advanced non-small cell lung cancer (NSCLC)
    Full story
  • Schizophrenia Genomics Study Looks for Somatic Mosaicism in Brain Cells

    May 20, 2015, 12:00 PM by Michael Croft
    Bio-IT World | The Lieber Institute for Brain Development (LIBD) announced a 5-year, $10.5 million grant from the National Institutes of Health (NIH) to support a first-of-its-kind multi-site, interdisciplinary project to research potentially non-inherited genetic causes of schizophrenia. By identifying the root biological origins now, more precise and effective therapies can be developed later.
    Full story
  • Celgene to Use Cypher Genomics’ Data Analytics in Drug Development

    May 20, 2015, 00:00 AM by Michael Croft
    Xconomy | Under a collaboration announced today, San Diego-based Cypher Genomics said it would use its biomarker discovery service to help New Jersey's Celgene identify key genetic variants among patients who respond well to specific drugs.
    Full story
  • Robert Gentleman on His Goals for Drug Discovery at 23andMe

    May 19, 2015, 11:00 AM by Michael Croft
    Bio-IT World | Robert Gentleman’s goal is to “bring bioinformatics and computational drug discovery to complement the really strong genetics” already at 23andMe. He spoke with Bio-IT World about open science at a for-profit venture, the challenges of drug discovery, and what’s left to find via SNP chips.
    Full story
  • AWS upgrades highlight growing focus on cloud management

    May 19, 2015, 00:00 AM by Michael Croft
    Computerworld | Amazon Web Services is hoping better management tools will convince enterprises to move more applications to the cloud, but getting their internal management processes right is even more important than anything the vendor can offer.
    Full story
  • Bluebird Regulators Map Out Approval Plan For Gene Therapy

    May 19, 2015, 00:00 AM by Michael Croft
    Xconomy | One of gene therapy's major unanswered questions is just what it'll take to convince U.S. regulators to approve one of these treatments.
    Full story
  • Latest Report - Enterprise ICT investment plans-ICT budget and staffing trends in Pharmaceuticals

    May 18, 2015, 00:00 AM by Michael Croft
    SAN FRANCISCO, CA, UNITED STATES - May 18, 2015 - Product Synopsis
     
    This report presents the findings from a survey of 102 pharmaceutical companies regarding their Information and Communications Technology (ICT) budgets and staff allocation
    Full story
  • Kapa Biosystems Launches New RNA Prep Kit to Maximize Sequencing Efficiency

    May 18, 2015, 00:00 AM by Michael Croft
    WILMINGON, MA, UNITED STATES - May 18, 2015 - Kapa Biosystems, Inc., today launched a new RNA library preparation product for next-generation sequencing (NGS) workflows that enables users to generate a more complete view of the transcriptome by detecting more low-abundance and unique transcripts
    Full story
  • Can We Identify Every Kind of Cell in the Body

    May 18, 2015, 00:00 AM by Michael Croft
    MIT Technology Review | With new tools to isolate individual cells and profile their genetic signatures, researchers are undertaking a microscopic quest to find out what we're really made of.
    Full story
  • Unlocking the Value of Smart Data & Analytics at Smart Data Summit Dubai Next Week

    May 18, 2015, 00:00 AM by Michael Croft
    DUBAI, UNITED ARAB EMIRATES - May 18, 2015 - The 2nd Annual Smart Data Summit will take place next week on 25-26 May at Sofitel Dubai The Palm Resort and Spa, Dubai, UAE
    Full story
  • Michael J. Fox Foundation Brings Parkinson's Data to tranSMART

    May 15, 2015, 10:15 AM by Michael Croft
    Bio-IT World | The Michael J. Fox Foundation, dedicated to driving basic research in Parkinson's disease, received a special Judges' Prize at this year's Bio-IT World Best Practices Awards for its work implementing the tranSMART platform for data sharing and analysis, including innovative programs like a patient registry and integration with studies of other neurodegenerative diseases.
    Full story
  • Oxford Nanopore Announces Auto Sample Prep, New Chips, Pay-As-You-Go Pricing

    May 14, 2015, 14:00 PM by Michael Croft
    Bio-IT World | Clive Brown’s Oxford Nanopore took over our Twitter feed on Thursday afternoon with news coming out of the London Calling event (#nanoporeconf). Many in attendance (and watching the Twitter feed) called the announcements “game-changing” and likened the atmosphere to Apple’s iPhone announcement in 2007. 
    Full story
  • Mayo Clinic Embarks on Population-Scale Pharmacogenomics Study

    May 14, 2015, 10:00 AM by Michael Croft
    Bio-IT World News Brief | Mayo Clinic in Rochester, Minn., has announced plans to sequence genes from 10,000 patients for genetic variants that could affect their responses to a variety of medications, as part of a study that will track the long-term health outcomes of patients who undergo pharmacogenetic testing.
    Full story
  • Allen Institute Debuts Neuron Periodic Table

    May 14, 2015, 00:00 AM by Michael Croft
    Xconomy | With the Allen Cell Types Database, the Allen Institute for Brain Science aims to catalog and classify the types of neurons that fill the brain.
    Full story
  • Genentech Brain Trust Raises $217m For New Startup To Fight Alzheimers And Parkinsons

    May 14, 2015, 00:00 AM by Michael Croft
    Forbes | Three former top researchers at Genentech, the legendary biotech that is now part of Roche Holding, have raised $217 million in venture capital to start a new company, Denali Therapeutics, focused on treating and curing neurodegenerative diseases like Alzheimer's, ALS, and Parkinson's.
    Full story
  • Citizen Science in the Unexplored Terrain of the Brain

    May 13, 2015, 10:25 AM by Michael Croft
    Bio-IT World | To understand how neural circuits give rise to complex mental phenomena, neuroscientists need detailed maps of brain cells in their natural environment. With an online game called EyeWire, one group of researchers is enlisting thousands of ordinary people to do what the best artificial intelligence cannot: turn huge numbers of electron microscope images of the retina into accurate, three-dimensional models of neurons as they appear in living tissue.
    Full story
  • Cleversafe Joins iRODS Consortium

    May 12, 2015, 14:00 PM by Michael Croft
    Bio-IT World | Cleversafe, a private cloud platform, announced today that it has joined the iRODS Consortium, a membership-based foundation organized to sustain the integrated Rule-Oriented Data System (iRODS) as free open source data management software. 
    Full story
  • Genedata Screener Now Supports Streamlined Collaboration among Pharmas and CROs

    May 12, 2015, 00:00 AM by Michael Croft
    BASEL, SWITZERLAND - May 12, 2015 - Genedata, a leading provider of advanced software solutions for drug discovery and life science research, today announced that the Genedata Screener® platform supports data- and result-sharing with Contract Research Organizations (CROs)
    Full story